Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001209191-18-011264

Director acquired 16,483 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lydon Nicholas · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-02-15 Exercise or conversion : show line 1 in the form +16,483 $4.55 $74,998 304,106 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-02-15 Exercise or conversion : show line 2 in the form Series C Preferred Stock Warrant (right to buy) −16,483 $4.55 2018-11-04 16,843 0 D
Loading xslF345X03/doc4.xml…